share_log
Breakings ·  Jul 19 19:21
Neurocrine Biosciences Inc : BMO Raises Target Price to $142 From $138
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment